Search Results for "activate"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for activate. Results 691 to 700 of 1334 total matches.
Nebivolol (Bystolic) for Hypertension
The Medical Letter on Drugs and Therapeutics • Mar 10, 2008 (Issue 1281)
and renin activity. At higher doses, it
antagonizes beta
2
receptors and could cause bronchospasm ...
Nebivolol (Bystolic - Forest) is a new beta-blocker that has been approved by the FDA for treatment of hypertension. It has been marketed in Europe since 1999 for treatment of hypertension and heart failure.
Drugs for Head Lice
The Medical Letter on Drugs and Therapeutics • Jun 10, 2024 (Issue 1704)
Killing
Shampoo, and others) to enhance their activity.
Pyrethrin formulations are unstable in heat ...
Pediculosis capitis (head lice infestations) occur in
all age groups, but especially in elementary school
children. In most cases, transmission occurs by
head-to-head contact. Pharmacologic treatment is
recommended for persons with live lice or eggs (nits)
within 1 cm of the scalp. Topical pediculicides should
be tried first. Oral therapy is occasionally required for
refractory infestations.
Med Lett Drugs Ther. 2024 Jun 10;66(1704):89-92 doi:10.58347/tml.2024.1704a | Show Introduction Hide Introduction
Gamma Hydroxy Butyrate Poisoning
The Medical Letter on Drugs and Therapeutics • Jan 25, 1991 (Issue 836)
, vomiting, dizziness, confusion, and drowsiness to depressed respiration and seizure-like activity. Some ...
Gamma hydroxy butyrate (GHB) sold in health food stores has recently caused outbreaks of gastrointestinal illness, central-nervous-system (CNS) depression, and seizures.
Eribulin Mesylate (Halaven) for Breast Cancer
The Medical Letter on Drugs and Therapeutics • Apr 18, 2011 (Issue 1362)
is an analog of
halichondrin B, a macrolide found in marine sponges
that has marked anticancer activity ...
Eribulin mesylate (Halaven – Eisai) has been
approved by the FDA for treatment of patients with
metastatic breast cancer who have previously
received at least 2 chemotherapy regimens for
metastatic cancer. Prior therapy should have
included an anthracycline and a taxane in either an
adjuvant or metastatic setting. Other drugs used to
treat anthracycline- and taxane-refractory metastatic
breast cancer include capecitabine (Xeloda),
gemcitabine (Gemzar, and others) and vinorelbine
(Navelbine, and others).
Sitagliptin and Simvastatin (Juvisync)
The Medical Letter on Drugs and Therapeutics • Nov 14, 2011 (Issue 1377)
inhibitor simvastatin (Zocor, and others).
ACTIVITY — Statins have been shown to lower the
risk ...
The FDA has approved Juvisync (Merck), a fixed-dose
combination of the antihyperglycemic DPP-4 inhibitor
sitagliptin (Januvia) and the HMG-CoA reductase
inhibitor simvastatin (Zocor, and others).
In Brief: New Indications for Secukinumab (Cosentyx)
The Medical Letter on Drugs and Therapeutics • Jun 06, 2016 (Issue 1496)
who continue to have
active psoriatic arthritis. The cost for one 150 mg/mL
single-use pen ...
The FDA has approved the subcutaneous IL-17A antagonist secukinumab (Cosentyx - Novartis), which was first approved in 2015 for treatment of plaque psoriasis, for treatment of psoriatic arthritis and ankylosing spondylitis in adults.1 Secukinumab is one of the most effective drugs available for treatment of plaque psoriasis.2FDA approval of secukinumab for treatment of psoriatic arthritis was based on two randomized, double-blind trials with a primary endpoint of at least a 20% improvement in the American College of Rheumatology response criteria (ACR20) at 24 weeks. In both trials, ACR20...
Antiviral Drugs for Varicella-Zoster Virus and Herpes Simplex Virus Infections
The Medical Letter on Drugs and Therapeutics • Sep 24, 2018 (Issue 1556)
for adequate antiviral activity.
7. Clinical trial data are lacking.
8. Antiviral treatment is recommended ...
The recommendations for treatment of varicella-zoster
virus (VZV) and herpes simplex virus (HSV)
infections are listed in tables 1 and 2. Vaccination
against VZV was reviewed in a previous issue.
Antimicrobial Prophylaxis for Surgery
The Medical Letter on Drugs and Therapeutics • May 23, 2016 (Issue 1495)
(Ancef, and others), a first-generation cephalosporin
active against many staphylococci and streptococci ...
Antimicrobial prophylaxis can decrease the
incidence of postoperative surgical site infection
after some procedures. Since the last Medical Letter
article on this subject, consensus guidelines have
been published. Recommendations for prophylaxis
in specific surgical procedures are listed in Table 1.
Drugs for Thyroid Disorders
Treatment Guidelines from The Medical Letter • Aug 01, 2009 (Issue 84)
, as needed, of biologically
inactive T4 into biologically active triiodothyronine
(T3). In a study of 50 ...
Primary hypothyroidism is usually the result of Hashimoto's thyroiditis, thyroidectomy for hyperthyroidism, goiter or cancer, or radioactive iodine therapy for hyperthyroidism.
Isosorbide Mononitrate for Angina
The Medical Letter on Drugs and Therapeutics • Jun 26, 1992 (Issue 873)
for prophylactic use in patients
with chronic stable angina. ISMN is the major active metabolite of isosorbide ...
Isosorbide mononitrate (ISMN; Ismo - Wyeth-Ayerst), an oral nitrate long available in Europe, was recently approved by the US Food and Drug Administration for prophylactic use in patients with chronic stable angina. ISMN is the major active metabolite of isosorbide dinitrate (ISDN; Isordil, and others).